Your browser doesn't support javascript.
loading
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica.
Dejaco, Christian; Kerschbaumer, Andreas; Aletaha, Daniel; Bond, Milena; Hysa, Elvis; Camellino, Dario; Ehlers, Lisa; Abril, Andy; Appenzeller, Simone; Cid, Maria C; Dasgupta, Bhaskar; Duftner, Christina; Grayson, Peter C; Hellmich, Bernhard; Hocevar, Alojzija; Kermani, Tanaz A; Matteson, Eric L; Mollan, Susan P; Neill, Lorna; Ponte, Cristina; Salvarani, Carlo; Sattui, Sebastian Eduardo; Schmidt, Wolfgang A; Seo, Philip; Smolen, Josef S; Thiel, Jens; Toro-Gutiérrez, Carlos Enrique; Whitlock, Madeline; Buttgereit, Frank.
  • Dejaco C; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Medical University, Graz, Austria christian.dejaco@gmx.net.
  • Kerschbaumer A; Rheumatology, Hospital of Bruneck (ASAA-SABES), Teaching Hospital of the Paracelsius Medical University, Brunico, Italy.
  • Aletaha D; Abteilung für Rheumatologie, Medizinische Universitat Wien Universitatsklinik fur Innere Medizin III, Wien, Austria.
  • Bond M; Department of Rheumatology, Medizinische Universität Wien, Wien, Austria.
  • Hysa E; Rheumatology, Hospital of Bruneck (ASAA-SABES), Teaching Hospital of the Paracelsius Medical University, Brunico, Italy.
  • Camellino D; Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, University of Genoa, Genova, Italy.
  • Ehlers L; Division of Rheumatology, Department of Medical Specialties, Azienda Sanitaria Locale 3 Genovese, Arenzano, Italy.
  • Abril A; Department of Rheumatology and Clinical Immunology, Charite Medical Faculty Berlin, Berlin, Germany.
  • Appenzeller S; Rheumatology, Mayo Clinic, Jacksonville, Florida, USA.
  • Cid MC; Departamento de Clínica Médica. Facultade de Ciências Medicas da UNICAMP, Universidade Estadual de Campinas, Campinas, Brazil.
  • Dasgupta B; Department of Autoimmune Diseases, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Duftner C; Rheumatology, Southend Hospital NHS Trust, Westcliff-on-sea, UK.
  • Grayson PC; Department of Internal Medicine, Clinical Division of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria.
  • Hellmich B; National Institutes of Health/NIAMS, Bethesda, Maryland, USA.
  • Hocevar A; Klinik für Innere Medizin, Rheumatolgie und Immunologie, Medius Kliniken Kirchheim/Teck, University Tübingen, Kirchheim-Teck, Germany.
  • Kermani TA; Department of Rheumatology, Universitiy Medical Centre, Ljubljana, Slovenia.
  • Matteson EL; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
  • Mollan SP; Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Neill L; Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Ponte C; Ophthalmology, University Hospitals Birmingham, Birmingham, UK.
  • Salvarani C; Neurometabolism, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
  • Sattui SE; Patient Charity Polymyalgia Rheumatica and Giant Cell Arteritis Scotland, Nethy Bridge, UK.
  • Schmidt WA; Rheumatology, Centro Hospitalar Universitario Lisboa Norte EPE, Lisboa, Portugal.
  • Seo P; Rheumatology Research Unit, Instituto de Medicina Molecular, Lisboa, Portugal.
  • Smolen JS; Unit of Rheumatology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.
  • Thiel J; Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Toro-Gutiérrez CE; Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Whitlock M; Rheumatology, Immanuel Krankenhaus Berlin, Berlin-Buch, Berlin, Germany.
  • Buttgereit F; Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA.
Ann Rheum Dis ; 83(1): 48-57, 2024 Jan 02.
Article en En | MEDLINE | ID: mdl-36828585
ABSTRACT

OBJECTIVES:

To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR).

METHODS:

A systematic literature review was conducted to retrieve data on treatment targets and outcomes in GCA/PMR as well as to identify the evidence for the effectiveness of a T2T-based management approach in these diseases. Based on evidence and expert opinion, the task force (29 participants from 10 countries consisting of physicians, a healthcare professional and a patient) developed recommendations, with consensus obtained through voting. The final level of agreement was provided anonymously.

RESULTS:

Five overarching principles and six-specific recommendations were formulated. Management of GCA and PMR should be based on shared decisions between patient and physician recognising the need for urgent treatment of GCA to avoid ischaemic complications, and it should aim at maximising health-related quality of life in both diseases. The treatment targets are achievement and maintenance of remission, as well as prevention of tissue ischaemia and vascular damage. Comorbidities need to be considered when assessing disease activity and selecting treatment.

CONCLUSION:

These are the first T2T recommendations for GCA and PMR. Treatment targets, as well as strategies to assess, achieve and maintain these targets have been defined. The research agenda highlights the gaps in evidence and the need for future research.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polimialgia Reumática / Arteritis de Células Gigantes Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polimialgia Reumática / Arteritis de Células Gigantes Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article